Related Experiment Video

Updated: Jul 5, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.3K

Albuminuria: An Underappreciated Risk Factor for Cardiovascular Disease

Joshua I Barzilay1, Youssef M K Farag2, Jeffrey Durthaler2

  • 1Division of Endocrinology Kaiser Permanente of Georgia Duluth GA USA.

Journal of the American Heart Association
|January 12, 2024
PubMed

Insights

Albuminuria indicates kidney damage and cardiovascular disease risk. Early screening and management of albuminuria can reduce cardiovascular events and improve patient outcomes.

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Medicine

Background:

  • Albuminuria is a key indicator of chronic kidney disease progression.
  • Elevated albuminuria signifies kidney damage and systemic vascular disease, including arterial stiffness and myocardial capillary disease.
  • Albuminuria is linked to increased risks of coronary artery disease, stroke, heart failure, arrhythmias, and microvascular disease.

Purpose of the Study:

  • To highlight the significance of albuminuria as a cardiovascular disease risk biomarker.
  • To emphasize the availability of therapeutic agents for albuminuria lowering and cardiovascular risk reduction.
  • To underscore the importance of increased albuminuria screening and multidisciplinary management in cardiovascular disease patients.

Main Methods:

  • Literature review on albuminuria as a biomarker.
  • Analysis of the association between albuminuria and cardiovascular events.
  • Evaluation of therapeutic strategies for albuminuria reduction.

Main Results:

  • Albuminuria is a validated biomarker for predicting cardiovascular disease.
  • Therapeutic interventions targeting albuminuria can decrease cardiovascular risk.
  • Current screening rates for albuminuria remain suboptimal.

Conclusions:

  • Healthcare professionals must recognize the prognostic value of albuminuria for cardiovascular risk.
  • Multidisciplinary management incorporating albuminuria surveillance is crucial for cardiovascular patients.
  • Enhanced screening and management of albuminuria can mitigate cardiovascular morbidity and mortality.

Keywords:
albuminuriacardiovascular diseasechronic kidney diseasediabetes

More Related Videos

Assessment of Kidney Function in Mouse Models of Glomerular Disease09:16

Assessment of Kidney Function in Mouse Models of Glomerular Disease

Published on: June 30, 2018

17.7K
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

20.6K

Related Concept Videos

Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
2.2K
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
59
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
95
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
93
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
160